Actively Recruiting

Phase 1
Age: 18Years - 75Years
All Genders
NCT01731444

Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury

Led by University of Manitoba · Updated on 2026-05-14

24

Participants Needed

1

Research Sites

734 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The standard of care for treatment of burn injury is to inject a solution of epinephrine under the skin of the injured site in order to reduce blood loss during skin grafting. This solution of epinephrine has been shown to have effects on the body outside the donor site. Some people have increases in heart rate and blood pressure. We will study the effect of a phenylephrine solution in place of an epinephrine solution to control blood loss. We think that phenylephrine will help decrease blood loss and not change blood pressure or heart rate. The injured area will be injected under the skin and a skin graft will be taken in the same way as we usually do. The only change will be the use of phenylephrine in the solution instead of epinephrine. Our goal is to find whether or not phenylephrine or epinephrine solution results in a reduction of blood loss without affecting the rest of the body.

CONDITIONS

Official Title

Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Burn injury requiring debridement and grafting between 5-30% TBSA
Not Eligible

You will not qualify if you...

  • Head and neck, hand, foot, or genital burns
  • On anticoagulants (except NSAIDs)
  • On monoamine oxidase inhibitor or tricyclic antidepressant
  • Coronary or peripheral vascular disease
  • History of arrhythmias
  • On a Beta-blocker
  • History of vascular abnormality
  • Hypertension

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Manitoba

Winnipeg, Manitoba, Canada, R3A 1R9

Actively Recruiting

Loading map...

Research Team

J

Justin Gawaziuk, MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here